LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 80.88 | 17.25 | 270 | 5826 | 0.0463 | 0.3874 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.85 | 17.25 | 1 | 5861 | 0.0002 | -0.2873 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.85 | 17.25 | 957 | 5861 | 0.1633 | 0.6122 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.85 | 17.25 | 1 | 5861 | 0.0002 | -0.2873 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 82.85 | 17.25 | 234 | 5861 | 0.0399 | 0.3636 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.82 | 17.25 | 981 | 5924 | 0.1656 | 0.6156 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 84.82 | 17.25 | 217 | 5924 | 0.0366 | 0.3506 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.79 | 17.25 | 1067 | 6008 | 0.1776 | 0.6298 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 86.79 | 17.25 | 248 | 6008 | 0.0413 | 0.3712 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.76 | 17.25 | 1120 | 6047 | 0.1852 | 0.6383 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.76 | 17.25 | 1 | 6047 | 0.0002 | -0.2860 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 88.76 | 17.25 | 167 | 6047 | 0.0276 | 0.3081 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 90.74 | 17.25 | 1078 | 6109 | 0.1764 | 0.6295 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 90.74 | 17.25 | 1 | 6109 | 0.0002 | -0.2856 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 90.74 | 17.25 | 190 | 6109 | 0.0311 | 0.3275 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.71 | 17.25 | 1161 | 6184 | 0.1877 | 0.6422 | MN20160310_N02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 92.71 | 17.25 | 163 | 6184 | 0.0264 | 0.3030 | MN20160310_N02 | K04 |